These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2663384)

  • 1. Critical events in tumour suppression.
    Ciba Found Symp; 1989; 142():234-41. PubMed ID: 2663384
    [No Abstract]   [Full Text] [Related]  

  • 2. The biology of tumour suppression.
    Harris H
    Ciba Found Symp; 1989; 142():199-208; discussion 208-13. PubMed ID: 2743832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of transformed and malignant phenotypes in somatic cell hybrids between tumorigenic Chinese hamster cells and diploid mouse fibroblasts.
    Schäfer R; Doehmer J; Drüge PM; Rademacher I; Willecke K
    Cancer Res; 1981 Mar; 41(3):1214-21. PubMed ID: 7459862
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fusion of cultured Djungarian hamster tumor cells with the host cells in vivo and the characteristics of the hybrids obtained].
    Malakhova EM; Kakpakova ES
    Genetika; 1984 Jul; 20(7):1155-63. PubMed ID: 6540728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R; Kraemer PM; Proffitt MR; Culp LA
    Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
    Schäfer R; Hoffmann H; Willecke K
    Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells].
    Kakpakova ES
    Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF).
    Shi YP; Ferrara N
    Biochem Biophys Res Commun; 1999 Jan; 254(2):480-3. PubMed ID: 9918864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosome del(12)(q13).
    Bérubé NG; Speevak MD; Chevrette M
    Cancer Res; 1994 Jun; 54(12):3077-81. PubMed ID: 8205520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.
    Kashani-Sabet M; Funato T; Florenes VA; Fodstad O; Scanlon KJ
    Cancer Res; 1994 Feb; 54(4):900-2. PubMed ID: 8313379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.
    Kruzelock RP; Cuevas BD; Wiener JR; Xu FJ; Yu Y; Cabeza-Arvelaiz Y; Pershouse M; Lovell MM; Killary AM; Mills GB; Bast RC
    Oncogene; 2000 Dec; 19(54):6277-85. PubMed ID: 11175342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from studies on tumor suppression by microcell-mediated chromosome transfer.
    Oshimura M
    Environ Health Perspect; 1991 Jun; 93():57-8. PubMed ID: 1773802
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor gene WT1 inhibits ras-mediated transformation.
    Luo XN; Reddy JC; Yeyati PL; Idris AH; Hosono S; Haber DA; Licht JD; Atweh GF
    Oncogene; 1995 Aug; 11(4):743-50. PubMed ID: 7651738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.